TOPLINE: In a US real-world analysis, only 51.5% of children with vitiligo received any treatment within 2 years of diagnosis, less often than adults. METHODOLOGY: Researchers […]

TOPLINE: Patients with autoimmune skin diseases (ASDs) showed significantly lower risks for death after cancer treatment than those without ASDs, especially those with alopecia areata or […]

TOPLINE: Intermittent treatment with pimecrolimus 1% cream for 1 year was effective in reversing topical corticosteroid-induced skin damage in patients with atopic dermatitis. Pimecrolimus reduced skin […]

TOPLINE: In a network meta-analysis of 25 randomized trials, sonelokimab was ranked highest for treating patients with moderate-to-severe hidradenitis suppurativa (HS). Adalimumab, lutikizumab, and bimekizumab were […]

TOPLINE: A series of retrospective studies reported that women treated with low-dose oral minoxidil (LDOM) experience orthostatic symptoms more frequently than men, despite normal blood pressure […]

TOPLINE: In a meta-analysis of 42 studies, exposure to air pollutants and high temperatures was associated with higher risk for clinic visits and worsened symptoms in […]

TOPLINE: In the VISIBLE trial, guselkumab led to significant and sustained improvements in scalp psoriasis severity and quality of life in patients with skin of color […]